Frischer T, Halmerbauer G, Gartner C, Rath R, Tauber E, Schierl M, Koller D Y, Urbanek R, Förster J, Kühr J
University Children's Hospital, Vienna, Austria.
Allergy. 2000 Aug;55(8):773-7. doi: 10.1034/j.1398-9995.2000.00773.x.
Eosinophilic airways inflammation forms the pathophysiologic basis for a proportion of children at risk of developing recurrent wheezing. Early preventive measures and/or anti-inflammatory treatment may be guided by the identification of such children.
We studied upper-airways inflammation by nasal lavage in a cohort of 397 infants within the first 4 weeks of life. They participated in an international multicenter study on the prevention of allergy in Europe (SPACE-Biomed II Program). A volume of 2 ml of prewarmed 0.9% saline was instilled into each nasal cavity and immediately re-collected by a suction device. The average recovery was 502 microl (SD: 311 microl). The concentrations of eosinophil cationic protein (ECP) and eosinophil protein X (EPX) were determined by RIA analysis.
ECP was detectable (>2 microg/l) in 47% of samples (173/365) and EPX (>3 microg/l) in 54.7% (197/360). Children with a doctor's diagnosis of a wheezy bronchitis within the first 6 months of life (n = 40) had significantly higher ECP and EPX concentrations in the nasal lavage at 4 weeks of age (median ECP: 14 microg/l; 5-95th percentile: 0-122.4 microg/l) than children without such diagnosis (median ECP: 0 microg/l; 5-95th percentile: 0-86.6 microg/l; P<0.05). Corresponding figures for EPX were 12.14 microg/l (0-148.98 microg/l) vs 7.5 microg/l (0-81.46 microg/l; P<0.05). No associations between nasal ECP/EPX and the development of food allergy or eczema were observed.
Increased nasal ECP and EPX in the first 4 weeks of life are associated with wheezing in 6-month-old infants at increased risk of atopic disease. We suggest that this might be related to a general tendency for a Th2 cytokine pattern in these young infants and subsequent trafficking of eosinophils into the nasal mucosa, or it might be a consequence of intrauterine allergen exposure.
嗜酸性气道炎症是一部分有复发性喘息风险儿童的病理生理基础。此类儿童的识别可为早期预防措施和/或抗炎治疗提供指导。
我们在397名出生后4周内的婴儿队列中,通过鼻腔灌洗研究上呼吸道炎症。他们参与了欧洲一项关于预防过敏的国际多中心研究(SPACE - Biomed II项目)。将2毫升预热的0.9%盐水滴入每个鼻腔,然后立即用抽吸装置重新收集。平均回收量为502微升(标准差:311微升)。通过放射免疫分析测定嗜酸性阳离子蛋白(ECP)和嗜酸性粒细胞蛋白X(EPX)的浓度。
47%的样本(173/365)中可检测到ECP(>2微克/升),54.7%(197/360)的样本中可检测到EPX(>3微克/升)。在出生后6个月内有医生诊断为喘息性支气管炎的儿童(n = 40),其4周龄时鼻腔灌洗中的ECP和EPX浓度显著高于无此类诊断的儿童(ECP中位数:14微克/升;第5 - 95百分位数:0 - 122.4微克/升)(ECP中位数:0微克/升;第5 - 95百分位数:0 - 86.6微克/升;P<0.05)。EPX的相应数据为12.14微克/升(0 - 148.98微克/升)对比7.5微克/升(0 - 81.46微克/升;P<0.05)。未观察到鼻腔ECP/EPX与食物过敏或湿疹的发生之间存在关联。
出生后4周内鼻腔ECP和EPX升高与患特应性疾病风险增加的6个月大婴儿的喘息有关。我们认为,这可能与这些幼儿中Th2细胞因子模式的总体倾向以及随后嗜酸性粒细胞向鼻黏膜的迁移有关,或者可能是宫内过敏原暴露的结果。